Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners ; volume:40 ; number:02 ; year:2019 ; pages:257-264
Indian journal of medical & paediatric oncology ; 40, Heft 02 (2019), 257-264
- Contributor
-
Krishnan, Shalini
Shetty, Vijith
Shetty, Jayarama
Babu, Gogineni Subhas
Rajeev, TP
- DOI
-
10.4103/ijmpo.ijmpo_20_18
- URN
-
urn:nbn:de:101:1-2021081213114844314833
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krishnan, Shalini
- Shetty, Vijith
- Shetty, Jayarama
- Babu, Gogineni Subhas
- Rajeev, TP
Other Objects (12)
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats
Bisphosphonate related osteonecrosis of the jaws: An update
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats
Bisphosphonate related osteonecrosis of the jaws: An update
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats